These findings indicate that TRPV6 increases NFATc2 transcriptional activity by targeting NFATc2IP phosphorylation, which finally upregulates ADAMTS6 expression to stimulate breast cancer metastasis [260]. The gene discussed is TRPV6; the disease is breast carcinoma.